Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 581,906 | 393,026 | 410,280 | 400,687 | 434,498 |
| Income taxes - deferred | 96,684 | -29,410 | 73,101 | -29,271 | 34,026 |
| Accounts receivable | 53,122 | 74,062 | 199,159 | -254,648 | -46,185 |
| Accounts payable and accrued liabilities | -113,267 | 77,272 | 1,311,586 | 98,026 | -131,077 |
| Other Working Capital | -130,726 | 45,634 | 1,422,486 | -101,931 | -71,347 |
| Other Operating Activity | 96,466 | 185,069 | -1,097,361 | 471,204 | 550,794 |
| Operating Cash Flow | $584,185 | $745,653 | $2,319,251 | $584,067 | $770,709 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -300,921 | -238,859 | -216,092 | -280,533 | -336,374 |
| Net Acquisitions | -101,931 | -46,147 | -64,499 | -31,800 | -204,418 |
| Purchase Of Investment | -66,255 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 14,759 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -2,664 | 0 | 0 | 0 |
| Investing Cash Flow | $-454,348 | $-287,670 | $-280,591 | $-312,333 | $-540,792 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -314,241 | -487,080 | -1,151,862 | 856,304 | -761,994 |
| Debt Issued | 11,633 | 845,049 | 1,251,559 | 12,664 | 1,870,961 |
| Debt Repayment | -221,446 | -650,184 | -673,270 | -745,117 | -809,639 |
| Common Stock Repurchased | 0 | 0 | -149,865 | -216,123 | -135,339 |
| Dividend Paid | 0 | -351,170 | N/A | N/A | 0 |
| Other Financing Activity | -44,534 | -49,754 | -800,176 | 213,586 | -328,332 |
| Financing Cash Flow | $-568,588 | $-693,139 | $-1,523,614 | $121,314 | $-164,343 |
| Exchange Rate Effect | -78,369 | -55,618 | -30,665 | 4,281 | -22,905 |
| Beginning Cash Position | 1,598,659 | 1,889,433 | 1,405,052 | 1,007,723 | 965,054 |
| End Cash Position | 1,081,539 | 1,598,659 | 1,889,433 | 1,405,052 | 1,007,723 |
| Net Cash Flow | $-438,751 | $-235,156 | $515,046 | $393,048 | $65,574 |
| Free Cash Flow | |||||
| Operating Cash Flow | 584,185 | 745,653 | 2,319,251 | 584,067 | 770,709 |
| Capital Expenditure | -306,374 | -245,441 | -218,191 | -281,977 | -337,013 |
| Free Cash Flow | 277,811 | 500,212 | 2,101,060 | 302,090 | 433,696 |